. . . . . "351037" . "3"^^ . "The use of titrating algorythm %22Adjust to target%22 for insulin dose changes in patient with type 2 diabetes mellitus"@en . "1214-231X" . "RIV/00216208:11120/09:00002031" . . . . "Mokr\u00E1, Jaroslava" . . "S" . "Pl\u00ED\u0161kov\u00E1, Eva" . "Vyu\u017Eit\u00ED titra\u010Dn\u00EDho algoritmu %22Adjust to Target%22 p\u0159i \u00FAprav\u011B bolusov\u00FDch d\u00E1vek u pacienta s diabetes mellitus 2. typu l\u00E9\u010Den\u00E9ho intenzifikovan\u00FDm inzul\u00EDnov\u00FDm re\u017Eimem" . "2"^^ . "The use of titrating algorythm %22Adjust to target%22 for insulin dose changes in patient with type 2 diabetes mellitus"@en . . . "4"^^ . . "Inzulin glargine (Lantus) je modern\u00EDm n\u00E1strojem k l\u00E9\u010Db\u011B diabetes mellitus 1. i 2. typu nab\u00EDzej\u00EDc\u00EDm 24 hodinov\u00E9 pokryt\u00ED pot\u0159eb baz\u00E1ln\u00EDho inzul\u00EDnu nav\u00EDc ve v\u00EDcem\u00E9n\u011B stabiln\u00ED hladin\u011B. D\u016Fle\u017Eitou sou\u010D\u00E1st\u00ED spr\u00E1vn\u00E9ho nastaven\u00ED terapie je postupn\u00E1 titrace d\u00E1vek inzul\u00EDnu, s c\u00EDlem dosa\u017Een\u00ED norm\u00E1ln\u00EDch hodnot glyk\u00E9mie. Jednou z doporu\u010Dovan\u00FDch metod, jak m\u016F\u017Ee pacient samostatn\u011B titrovat d\u00E1vku glargine (Lantus) je metoda 3 denn\u00EDch krok\u016F s postupnou snahou o dosa\u017Een\u00ED c\u00EDlov\u00E9 rann\u00ED la\u010Dn\u00E9 glyk\u00E9mie <- 5,5 mmol/l. Kasuistika pod\u00E1v\u00E1 p\u0159\u00EDklad takov\u00E9ho to postupu u pacientky s diabetes mellitus 2. typu l\u00E9\u010Den\u00E9 intenzifikovan\u00FDm inzul\u00EDnov\u00FDm re\u017Eimem, u kter\u00E9 byly doposud u\u017E\u00EDvan\u00E9 hum\u00E1nn\u00ED inzul\u00EDny nahrazeny jeho analogy (lispro, glargine)." . "Vyu\u017Eit\u00ED titra\u010Dn\u00EDho algoritmu %22Adjust to Target%22 p\u0159i \u00FAprav\u011B bolusov\u00FDch d\u00E1vek u pacienta s diabetes mellitus 2. typu l\u00E9\u010Den\u00E9ho intenzifikovan\u00FDm inzul\u00EDnov\u00FDm re\u017Eimem" . "RIV/00216208:11120/09:00002031!RIV10-MSM-11120___" . "Suppl. 1" . "Bro\u017E, Jan" . "7" . . "Inzulin glargine (Lantus) je modern\u00EDm n\u00E1strojem k l\u00E9\u010Db\u011B diabetes mellitus 1. i 2. typu nab\u00EDzej\u00EDc\u00EDm 24 hodinov\u00E9 pokryt\u00ED pot\u0159eb baz\u00E1ln\u00EDho inzul\u00EDnu nav\u00EDc ve v\u00EDcem\u00E9n\u011B stabiln\u00ED hladin\u011B. D\u016Fle\u017Eitou sou\u010D\u00E1st\u00ED spr\u00E1vn\u00E9ho nastaven\u00ED terapie je postupn\u00E1 titrace d\u00E1vek inzul\u00EDnu, s c\u00EDlem dosa\u017Een\u00ED norm\u00E1ln\u00EDch hodnot glyk\u00E9mie. Jednou z doporu\u010Dovan\u00FDch metod, jak m\u016F\u017Ee pacient samostatn\u011B titrovat d\u00E1vku glargine (Lantus) je metoda 3 denn\u00EDch krok\u016F s postupnou snahou o dosa\u017Een\u00ED c\u00EDlov\u00E9 rann\u00ED la\u010Dn\u00E9 glyk\u00E9mie <- 5,5 mmol/l. Kasuistika pod\u00E1v\u00E1 p\u0159\u00EDklad takov\u00E9ho to postupu u pacientky s diabetes mellitus 2. typu l\u00E9\u010Den\u00E9 intenzifikovan\u00FDm inzul\u00EDnov\u00FDm re\u017Eimem, u kter\u00E9 byly doposud u\u017E\u00EDvan\u00E9 hum\u00E1nn\u00ED inzul\u00EDny nahrazeny jeho analogy (lispro, glargine)."@cs . "[36AC2B2E3B15]" . "titration; insulin; type 2 diabetes mellitus"@en . "\u0160ilhov\u00E1, Elena" . "Vyu\u017Eit\u00ED titra\u010Dn\u00EDho algoritmu %22Adjust to Target%22 p\u0159i \u00FAprav\u011B bolusov\u00FDch d\u00E1vek u pacienta s diabetes mellitus 2. typu l\u00E9\u010Den\u00E9ho intenzifikovan\u00FDm inzul\u00EDnov\u00FDm re\u017Eimem"@cs . . "11120" . "Vyu\u017Eit\u00ED titra\u010Dn\u00EDho algoritmu %22Adjust to Target%22 p\u0159i \u00FAprav\u011B bolusov\u00FDch d\u00E1vek u pacienta s diabetes mellitus 2. typu l\u00E9\u010Den\u00E9ho intenzifikovan\u00FDm inzul\u00EDnov\u00FDm re\u017Eimem"@cs . . "Kazuistiky v diabetologii" . "CZ - \u010Cesk\u00E1 republika" . "One of the most important factors for proper use of insulin in treatment of Type 2 diabetes mellitus is titrating of the dose. One of it\u00B4s method called %22Adjust to target%22 is described as used in one our patients."@en .